Document Detail


Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?
MedLine Citation:
PMID:  20655037     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study demonstrated a significant increase in myocardial infarction events with dabigatran compared with warfarin, provoking renewed interest in whether vitamin K antagonists are useful drugs for the prevention of myocardial infarction in high-risk patients with atrial fibrillation. Present analyses examined whether there was an increased risk of myocardial infarction associated with non-warfarin anticoagulants (Stroke Prevention with the ORal direct Thrombin Inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial Fibrillation III and IV, RE-LY, Amadeus) or "anticoagulant equivalents" (Atrial fibrillation Clopidogrel Trial with Irbesartan for the prevention of Vascular Events) in patients with atrial fibrillation who are prescribed anticoagulation for stroke thromboprophylaxis. The overall annual event rate for those receiving warfarin was 0.98% compared with 1.32% for those receiving comparators. Warfarin was associated with a significant reduction in myocardial infarction (relative risk 0.77; 95% confidence interval (CI), 0.63-0.95), an effect largely driven by the RE-LY trial. Sensitivity analyses, excluding RE-LY, revealed a nonsignificant reduction in myocardial infarctions (relative risk 0.83; 95% CI, 0.62-1.10); an analogous analysis excluding the Atrial fibrillation Clopidogrel Trial with Irbesartan for the prevention of Vascular Events demonstrated a significant reduction in myocardial infarctions (relative risk 0.80; 95% CI, 0.64-1.00). Warfarin might provide a protective effect against myocardial infarction compared with non-warfarin anticoagulants or "anticoagulation equivalents" in patients with atrial fibrillation who are prescribed anticoagulation for stroke thromboprophylaxis.
Authors:
Gregory Y H Lip; Deirdre A Lane
Related Documents :
18035917 - Efficacy and safety of fondaparinux in patients with acute coronary syndromes.
10478987 - Review of the fifth american college of chest physicians consensus conference on antith...
21745477 - Effects of different small hspb members on contractile dysfunction and structural chang...
16511607 - Ximelagatran.
8022047 - Determination of regional myocardial blood flow with 13n-ammonia positron emission tomo...
16641417 - In vitro evaluation of stent patency and in-stent stenoses in 10 metallic stents using ...
Publication Detail:
Type:  Journal Article; Meta-Analysis; Review     Date:  2010-07-23
Journal Detail:
Title:  The American journal of medicine     Volume:  123     ISSN:  1555-7162     ISO Abbreviation:  Am. J. Med.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-30     Completed Date:  2010-09-13     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  785-9     Citation Subset:  AIM; IM    
Affiliation:
University of Birmingham Centre for Cardiovascular Sciences, Birmingham, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use*
Atrial Fibrillation / complications*
Azetidines / therapeutic use
Benzimidazoles / therapeutic use
Benzylamines / therapeutic use
Biphenyl Compounds / therapeutic use
Humans
Myocardial Infarction / etiology,  prevention & control*
Pyridines / therapeutic use
Randomized Controlled Trials as Topic
Stroke / etiology,  prevention & control*
Tetrazoles / therapeutic use
Warfarin / therapeutic use*
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Azetidines; 0/Benzimidazoles; 0/Benzylamines; 0/Biphenyl Compounds; 0/Pyridines; 0/Tetrazoles; 138402-11-6/irbesartan; 2E18WX195X/dabigatran etexilate; 49HFB70472/ximelagatran; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autosomal-recessive early-onset retinitis pigmentosa caused by a mutation in PDE6G, the gene encodin...
Next Document:  Albizosides D and E, two new cytotoxic triterpene saponins from Albizia chinensis.